Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N.L. Bartlett
The 23-Gene Gene Expression-Based Assay Does Not Predict Interim Pet Scan Results After Abvd in Advanced Stage Classical Hodgkin Lymphoma in the Us Intergroup S0816 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcomes of Patients ≥ 65 Years of Age in Zuma-1, a Pivotal Phase 1/2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Refractory Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Beyond Maximum Grade: A Novel, Longitudinal Toxicity Over Time (Toxt) Adverse Event Analysis of Lenalidomide in Follicular Lymphoma in Calgb 50401 (Alliance)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response to Brentuximab Vedotin by Cd30 Expression: Results From Five Trials in Ptcl, Ctcl, and B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Dial Study (Dual Immunomodulation in Aggressive Lymphoma): Randomized Phase 2 Trial of Varlilumab Plus Nivolumab in Relapsed/Refractory Aggressive B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
An Ongoing Phase 1/1b Trial Investigating Novel Treatment Regimens With Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Investigating Safety and Preliminary Efficacy of Afm13 Plus Pembrolizumab in Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
